Skip to content

Sarcopenia & Frailty: Two Challenging Comorbidities of Chronic Liver Disease (M33)

1:45 PM – 3:15 PM ET

LEARNING OBJECTIVES

  1. Define and diagnosis sarcopenia and frailty in patients with chronic liver disease
  2. Describe the consequences of sarcopenia and frailty in patients with chronic liver disease 
  3. Evaluate treatment options for sarcopenia and frailty in patients with chronic liver disease


FACULTY AND TOPICS
Sarcopenia – Causes and Outcomes in Patients with Chronic Liver Disease
Matthias Pirlich, MD, PhD, Physician, Departments of Endocrinology, Gastroenterology, and Clinical Nutrition, Imperial Oak Outpatient Clinic, Berlin, Germany  

Frailty – Causes and Outcomes in Patients with Chronic Liver Disease
Andres Duarte-Rojo, MD, PhD, Associate Professor of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA 

The Cost of Sarcopenia and Frailty: Implementing Therapies for Patients with Chronic Liver Disease
Jeanette Hasse, PhD, RD, LD, FADA, CNSC, Transplant Nutrition Manager, Baylor Simmons Transplant Institute, Baylor University Medical Center; Editor-in-Chief, Nutrition in Clinical Practice, Dallas, TX 

MODERATOR
Jeanette Hasse, PhD, RD, LD, FADA, CNSC

CE Credit: 1.5 hours
Level: Intermediate
UAN: JA0002345-0000-21-039-L01-P

BPS Logo Blue_75w This session has been approved for BCNSP recertification credit of 1.5 hours.